<SEC-DOCUMENT>0001539513-12-000001.txt : 20120427
<SEC-HEADER>0001539513-12-000001.hdr.sgml : 20120427
<ACCEPTANCE-DATETIME>20120427192425
ACCESSION NUMBER:		0001539513-12-000001
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20111212
FILED AS OF DATE:		20120427
DATE AS OF CHANGE:		20120427

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imprimis Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001360214
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				450567010
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		437 S. HWY 101
		STREET 2:		STE 209
		CITY:			SOLANA BEACH
		STATE:			CA
		ZIP:			92075
		BUSINESS PHONE:		858-433-2800

	MAIL ADDRESS:	
		STREET 1:		437 S. HWY 101
		STREET 2:		STE 209
		CITY:			SOLANA BEACH
		STATE:			CA
		ZIP:			92075

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSDEL PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20070912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bywater Resources, Inc
		DATE OF NAME CHANGE:	20060421

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			DERMASTAR INTERNATIONAL, LLC
		CENTRAL INDEX KEY:			0001539513
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52998
		FILM NUMBER:		12791495

	BUSINESS ADDRESS:	
		STREET 1:		1302 WAUGH DRIVE
		STREET 2:		STE 618
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77019
		BUSINESS PHONE:		8584054448

	MAIL ADDRESS:	
		STREET 1:		1302 WAUGH DRIVE
		STREET 2:		STE 618
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77019
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0205</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2011-12-12</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001360214</issuerCik>
        <issuerName>Imprimis Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>IMMY</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001539513</rptOwnerCik>
            <rptOwnerName>DERMASTAR INTERNATIONAL, LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1302 WAUGH DRIVE</rptOwnerStreet1>
            <rptOwnerStreet2>STE 618</rptOwnerStreet2>
            <rptOwnerCity>HOUSTON</rptOwnerCity>
            <rptOwnerState>TX</rptOwnerState>
            <rptOwnerZipCode>77019</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>8240045</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series A Convertible Preferred Stock</value>
                <footnoteId id="F2"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.0017</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2012-02-28</value>
            </exerciseDate>
            <expirationDate>
                <value>2012-02-28</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>7498500</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Warrants</value>
                <footnoteId id="F3"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.185</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2012-04-30</value>
            </exerciseDate>
            <expirationDate>
                <value>2015-04-29</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>241308</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">DermaStar International, LLC (&quot;DermaStar&quot;) is the direct beneficial owner of 8,240,045 shares of the Issuer's common stock. Mr. Mark L. Baum and Mr. Robert Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power over the 8,240,045 shares of common stock owned by DermaStar. Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.</footnote>
        <footnote id="F2">DermaStar is the direct beneficial owner of 10 shares of the Issuer's Series A Convertible Preferred Stock (the &quot;Series A Preferred&quot;). The Series A Preferred are convertible into a total of 7,498,500 shares of Common Stock. Mr. Baum and Mr. Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power of the 7,498,500 shares of Common Stock underlying the Series A Preferred owned by DermaStar.  Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.</footnote>
        <footnote id="F3">DermaStar is the direct beneficial owner of warrants to purchase up to 241,308 shares of the Issuer's Common Stock at an exercise price of $1.185 (the &quot;Warrants&quot;). The Warrants expire on the third anniversary of the issuance date. Mr. Baum and Mr. Kammer are the managing members of DermaStar, and each holds an ownership interest in DermaStar, and as managing members of DermaStar, may be deemed to have voting and dispositive power of the Warrants and 241,308 shares of Common Stock underlying the Warrants owned by DermaStar.  Both Mr. Baum and Mr. Kammer disclaim beneficial ownership over such shares.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Mark L. Baum</signatureName>
        <signatureDate>2012-04-27</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
